Part I: Primary malignant non-Wilms' renal tumours in children

Lancet Oncology

Volumn 8, Issue 8, 2007, Pages 730-737

  Ahmed, Hashim Uddin ^b   Arya, Manit ^a,b   Levitt, Gill ^a   Duffy, Patrick G ^a   Mushtaq, Imran ^a   Sebire, Neil J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; VON HIPPEL LINDAU PROTEIN;

BONE METASTASIS; BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER STAGING; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION; CLEAR CELL CARCINOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; GENE MUTATION; GENETIC CODE; GENETIC RISK; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; MEDULLARY CARCINOMA; MESOBLASTIC NEPHROMA; MUTATIONAL ANALYSIS; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RENOGRAPHY; REVIEW; RHABDOID TUMOR;

ANGIOMYOLIPOMA; CARCINOMA, RENAL CELL; CHILD; HUMANS; KIDNEY NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; NEPHROMA, MESOBLASTIC; PROGNOSIS; SURVIVAL RATE;

EID: 34547542232     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70241-3     Document Type: Review

References (73)

1. Magnani C., Gatta G., Corazziari I., et al. Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis. Eur J Cancer 37 (2001) 678-686
2. Broecker B. Non-Wilms' renal tumours in children. Urol Clin North Am 27 (2000) 463-469
3. Lowe L., Isuani B., Heller R., et al. Pediatric renal masses: Wilms tumor and beyond. Radiographics 20 (2000) 1585-1603
4. Perlman E. Pediatric renal tumours: practical updates for the pathologist. Pediatr Dev Pathol 8 (2005) 320-338
5. Bruder E., Passera O., Harms D., et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 28 (2004) 1117-1132
6. Estrada C., Suthar A., Eaton S., and Cilento Jr. B. Renal cell carcinoma: Children's Hospital Boston experience. Urology 66 (2005) 1296-1300
7. Neumann H., Bender B., Berger D., et al. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 16 (1998) 1248-1254
8. Lopez-Beltran A., Scarpelli M., Montironi R., and Kirkali Z. 2004 WHO classification of the renal tumours of the adults. Eur Urol 49 (2006) 798-805
9. Renshaw A. Pediatric renal carcinomas: where do they fit in the new histologic classification of renal cell carcinoma?. Adv Anat Pathol 7 (2000) 135-140
10. Bruder E., Passera O., Harms D., et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 28 (2004) 1117-1132
11. Renshaw A., Granter S., Fletcher J., Kozakewich H., Corless C., and Perez-Atayde A. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol 23 (1999) 795-802
12. Argani P., and Ladanyi M. The evolving story of renal translocation carcinoma. Am J Clin Pathol 126 (2006) 332-334
13. Argani P., and Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med 25 (2005) 363-378
14. Sidhar S., Clark J., Gill S., et al. The t(X;1) (p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5 (1996) 1333-1338
15. Argani P., Antonescu C., Illei P., et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumour entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159 (2001) 179-192
16. Argani P., and Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble J., Sauter G., Epstein J., et al. (Eds). Pathology and genetics of tumours in the urinary system and male genital organs (2004), IARC Press, Lyon 37-38
17. Agani P., and Ladanyi M. Recent advances in pediatric renal neoplasia. Adv Anat Pathol 10 (2003) 243-260
18. Argani P., Lal P., Hutchinson B., et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27 (2003) 750-761
19. Rakheja D., Kapur P., Tomlinson G., and Margraf L. Pediatric renal cell carcinomas with Xp11.2 rearrangements are immunoreactive for hMLH1 and hMSH2 proteins. Pediatr Dev Pathol 8 (2005) 615-620
20. Argani P., Hawkins A., Griffin C., et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1; q12) chromosome translocation. Am J Pathol 158 (2001) 2089-2096
21. Davis I., His B.-L., Arroyo J., et al. Cloning of a novel alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q12) chromosome translocation. Proc Natl Acad Sci USA 100 (2003) 6051-6056
22. Argani P., Laé M., Hutchinson B., et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 29 (2005) 230-240
23. Chang K., and Folpe A. Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol 8 (2001) 273-275
24. Steingrimsson E., Tessarollo L., Reid S., Jenkins N., and Copeland N. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development 125 (1998) 4607-4616
25. Argani P., Perlman E., Breslow N., et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumour Study Pathology Center. Am J Surg Path 24 (2000) 4-18
26. Gonzalez-Crussi F., and Baum E. Renal sarcomas of childhood. A clinicopathologic and ultrastructural study. Cancer 51 (1983) 898-912
27. Iyer V., Agarwala S., and Verma K. Fine-needle aspiration cytology of clear-cell sarcoma of the kidney: study of eight cases. Diagn Cytopathol 33 (2005) 83-89
28. Krishnamurthy S., and Bharadwaj R. Fine needle aspiration cytology of clear-cell sarcoma of the kidney: a case report. Acta Cytol 42 (1998) 1444-1446
29. Akhtar M., Ali M., and Burgess A. Fine needle aspiration biopsy of clear-cell sarcoma of the kidney: light and electron microscopic features. Diagn Cytopathol 5 (1988) 181-187
30. Drut R., and Pomar M. Cytological characteristics of clear-cell sarcoma of the kidney (CCSK) in fine needle aspiration biopsy (FNAB): a report of 4 cases. Diagn Cytopathol 7 (1991) 611-614
31. Sandstedt B., Delemarre J., Harms D., et al. Sarcomatous Wilms' tumour with clear cells and hyalinization. A study of 38 tumours in children from the SIOP nephroblastoma file. Histopathology 11 (1987) 273-285
32. Kodet R., Stejskal J., Malis J., et al. Bone metastasizing renal tumor of childhood. A clinicopathological study of eleven cases from the Prague Pediatric Tumour Registry. Pathol Res Pract 190 (1994) 750-758
33. Looi L., and Cheah P. An immunhistochemical study comparing clear cell sarcoma of the kidney and Wilms' tumour. Pathology 25 (1993) 106-109
34. Cutcliffe C., Kersey D., Huang C., et al. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the Sonic Hedgehog and Akt Pathways. Clin Cancer Res 11 (2005) 7986-7994
35. Schuster A., Schneider D., Fritsch M., Grundy P., and Perlman E. Genetic and genetic expression analysis of clear cell sarcoma of the kidney. Lab Invest 83 (2003) 1293-1299
36. Glick R., Hicks M., Nuchtern J., Wesson D., Olutoye O., and Cass D. Renal tumors in infants less than 6 months of age. J Pediatr Surg 39 (2004) 522-525
37. Furtwaengler R., Reinhard H., Leuschner I., et al. Mesoblastic nephroma-a report from the Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). Cancer 106 (2006) 2275-2283
38. Sandstedt B., Delemarre J., Krul E., and Tournade M. Mesoblastic nephromas: a study of 29 tumours from the SIOP nephroblastoma file. Histopathology 9 (1985) 741-750
39. Argani P., and Beckwith J. Metanephric stromal tumor: report of 31 cases of a distinctive pediatric renal neoplasm. Am J Surg Pathol 24 (2000) 917-926
40. Knezevich S., Garnett M., Pysher T., et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 58 (1998) 5046-5048
41. Chen W., Lin C., Chao C., et al. Prenatal diagnosis of congenital mesoblastic nephroma in mid-second trimester by sonography and magnetic resonance imaging. Prenat Diagn 23 (2003) 927-931
42. Rousseau-Merck M., de Keyzer Y., Bourdeau A., Cournot G., Mercier F., and Nezelof C. PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia. Cancer 62 (1988) 303-308
43. Vido L., Carli M., Rizzoni G., et al. Congenital mesoblastic nephroma with hypercalcemia. Pathogenetic role of prostaglandins. Am J Pediatr Hematol Oncol 8 (1986) 149-152
44. Schenk J., Schrader C., Zieger B., et al. MRI-morphology and staging of congenital mesoblastic nephroma: evaluation of a collection with 20 patients. Rofo 177 (2005) 1373-1379 (in German).
45. Joshi V., Kasznica J., and Walters T. Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. Arch Pathol Lab Med 110 (1986) 100-106
46. O'Malley D., Mierau G., Beckwith J., and Weeks D. Ultrastructure of cellular congenital mesoblastic nephroma. Ultrastruct Pathol 20 (1996) 417-427
47. Argani P., Fritsch M., Kadkol S., Schuster A., Beckwith J., and Perlman E. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging paediatric renal stromal tumours. Mod Pathol 13 (2000) 29-36
48. Anderson J., Gibson S., and Sebire N. Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma. Histopathology 48 (2006) 748-753
49. Sugimura J., Yang X., Tretiakova M., et al. Gene expression profiling of mesoblastic nephroma and Wilms tumors-comparison and clinical implications. Urology 64 (2004) 362-368
50. Knezevich S., Garnett M., Pysher T., Beckwith J., Grundy P., and Sorensen P. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 58 (1998) 5046-5048
51. Knezevich S., McFadden D., Tao W., et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18 (1998) 184-187
52. Schofield D., Yunis E., and Fletcher J. Chromosome aberrations in mesoblastic nephroma. Am J Pathol 143 (1993) 714-724
53. Tognon C., Garnett M., Kenward E., et al. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-Kinase-Akt signalling for fibroblast transformation. Cancer Res 61 (2001) 8909-8916
54. Tognon C., Knezevich S., Huntsman D., et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2 (2002) 367-376
55. Haas J., Palmer N., Weinberg A., et al. Ultrastructure of malignant rhabdoid tumour of the kidney: a distinctive renal tumour of children. Hum Pathol 12 (1981) 646-657
56. Agrons G., Kingsman K., Wagner B., and Sotelo-Avila C. Rhabdoid tumor of the kidney in children: a comparative study of 21 cases. AJR Am J Roentgenol 168 (1997) 447-451
57. Argani P., and Beckwith J. Renal neoplasms of childhood. In: Mills S. (Ed). Sternberg's diagnostic surgical pathology. 4th edn. (2004), Lippincott Williams & Wilkins, Philadelphia 2001-2033
58. Weeks D., Beckwith J., and Mierau G. Rhabdoid tumor. An entity or a phenotype?. Arch Pathol Lab Med 113 (1989) 113-114
59. Weeks D., Beckwith J., Mierau G., et al. Renal neoplasms mimicking rhabdoid tumor of kidney: a report from the National Wilms' Tumour Study pathology center. Am J Surg Pathol 15 (1991) 1042-1054
60. Versteege I., Sevenet N., Lange J., et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394 (1998) 203-206
61. Hoot A., Russo P., Judkins A., Perlman E., and Biegel J. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumours from other paediatric soft tissue tumours. Am J Surg Pathol 28 (2004) 1485-1491
62. Burger P., Yu I.-T., Tihan T., et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol 22 (1998) 1083-1092
63. Savla J., Chen T.-Y., Schneider N., et al. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 92 (2000) 648-650
64. Davis C., Mostofi F., and Sesterhenn I. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 19 (1995) 1-11
65. Wesche W., Wilmas J., Khare V., and Parham D. Renal medullary carcinoma: a potential sickle cell nephropathy of children and adolescents. Pediatr Pathol Lab Med 18 (1998) 97-113
66. Avery R., Harris J., Davis C., et al. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer 78 (1996) 128-132
67. Leitao V., da Silva Jr. W., Ferreira U., Denardi F., Billis A., and Rodrigues Netto Jr. N. Renal medullary carcinoma. Case report and review of the literature. Urology 77 (2006) 184-186
68. Mitchell C., Pritchard-Jones K., Shannon R., et al. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer 42 (2006) 2554-2562
69. Blitman N., Berkenblit R., Rozenblit A., and Levin T. Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol 185 (2005) 268-272
70. Swartz M., Karth J., Schneider D., et al. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology 60 (2002) 1083-1089
71. Simpson L., He X., Pins M., et al. Renal medullary carcinoma and ABL gene amplification. J Urol 173 (2005) 1883-1888
72. Yang X., Sugimura J., Tretiakova M., et al. Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer 100 (2004) 976-985
73. Carmeliet P., Dor Y., Herbert J., et al. Role of HIF-alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490